Interleukin Genetics, Inc.
8
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
1 terminated/withdrawn out of 8 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Dental Engagement Study Behavior Modification
Role: lead
Genetic Polymorphisms Associated With CAD
Role: lead
Identification of Gene Biomarkers in Aging Skin
Role: lead
Genetics of Periodontal Diseases in European Caucasians
Role: collaborator
Genetics of Periodontal Diseases in Chinese
Role: collaborator
Genetics of Periodontal Diseases in Chinese (Taiwan)
Role: collaborator
Association of Genes to Resistance to Weight Loss in Obese Patients
Role: lead
A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs
Role: lead
All 8 trials loaded